Open Label, Dose Escalation, Repeat Dose Study Evaluating YCT-529 in Healthy Males — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Open Label, Dose Escalation, Repeat Dose Study Evaluating YCT-529 in Healthy Males — Stella

Home/Male Contraception/

View on ClinicalTrials.gov

Recruiting

Back to Male Contraception trials

Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.

Trial locations(1 site)

New Zealand

New Zealand Clinical Research (NZCR), Grafton, Auckland

Key details

Phase

Early testing / Safety & dosing

Sponsor

YourChoice Therapeutics, Inc.

Enrollment target

~88 participants

Started

September 2024

Primary completion

July 2026

Age range

28 Years – 70 Years

Sex

Male only

Last updated February 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.